Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Onxeo SA (CO: ONXEO)

 
ONXEO Technical Analysis
5
As on 8th Dec 2023 ONXEO STOCK Price closed @ 1.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.79 & Strong Sell for SHORT-TERM with Stoploss of 2.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ONXEOSTOCK Price

Open 1.30 Change Price %
High 1.30 1 Day 0.00 0.00
Low 1.30 1 Week 0.00 0.00
Close 1.30 1 Month 0.00 0.00
Volume N/A 1 Year -1.32 -50.38
52 Week High 2.84 | 52 Week Low 1.20
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 325.25 %
LEDIBOND 0.02 %
CONFRZ 0.02 0.00%
VJBA 7.33 0.41%
VWS 173.40 %
ORSTED 122.35 %
BIOPOR 1.02 %
DANSKE 318.60 %
BIF 0.27 %
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
SAME 1.45 10.69%
SAME 1.45 10.69%
ASTRLS 1.15 8.49%
MAPS 0.37 5.71%
MAPS 0.37 5.71%
MAPS 0.37 5.71%
MAPS 0.37 5.71%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
ONXEO
Daily Charts		 ONXEO
Intraday Charts		 Whats New @
Bazaartrend		 ONXEO
Free Analysis
 
ONXEO Important Levels Intraday
RESISTANCE1.30
RESISTANCE1.30
RESISTANCE1.30
RESISTANCE1.30
RESISTANCE1.30
RESISTANCE1.30
RESISTANCE1.30
RESISTANCE1.30
 
ONXEO Forecast December 2025
Share
4th UP Forecast2.46
3rd UP Forecast2.09
2nd UP Forecast1.86
1st UP Forecast1.63
1st DOWN Forecast0.97
2nd DOWN Forecast0.74
3rd DOWN Forecast0.51
4th DOWN Forecast0.14
 
ONXEO Weekly Forecast
4th UP Forecast1.80
3rd UP Forecast1.64
2nd UP Forecast1.54
1st UP Forecast1.44
1st DOWN Forecast1.16
2nd DOWN Forecast1.06
3rd DOWN Forecast0.96
4th DOWN Forecast0.80
 
ONXEO Forecast2025
4th UP Forecast4.83
3rd UP Forecast3.7
2nd UP Forecast3
1st UP Forecast2.3
1st DOWN Forecast0.3
2nd DOWN Forecast-0.4
3rd DOWN Forecast-1.1
4th DOWN Forecast-2.23
 
 
ONXEO Other Details
Segment EQ
Market Capital 345741696.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ONXEO Address
ONXEO
 
ONXEO Latest News
 
Your Comments and Response on Onxeo SA
 
ONXEO Business Profile
Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. The company offers Beleodaq for the treatment of peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for treating DNA damage response and immuno-oncology; and platON, a decoy oligonucleotide platform. Onxeo SA has a collaboration and licensing agreement with Spectrum Pharmaceuticals for the development of Beleodaq; a license agreement with Acrotech Biopharma LLC; and clinical research agreement with Gustave Roussy to conduct clinical trial of AsiDNA for the treatment of relapsed ovarian cancer. The company was formerly known as BioAlliance Pharma SA and changed its name to Onxeo SA in July 2014. Onxeo SA was incorporated in 1997 and is headquartered in Paris, France. Address: 49, boulevard du GEnEral Martial Valin, Paris, France, 75015
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service